APA aipamena

Zhang, F., Huang, D., Li, T., Zhang, S., Wang, J., Zhang, Y., . . . Hu, Y. (2020). Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer. J Cancer.

Chicago Style aipamena

Zhang, Fan, et al. "Anti-PD-1 Therapy Plus Chemotherapy And/or Bevacizumab As Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer." J Cancer 2020.

MLA aipamena

Zhang, Fan, et al. "Anti-PD-1 Therapy Plus Chemotherapy And/or Bevacizumab As Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer." J Cancer 2020.